A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT07259980 · RECRUITING
Trial details
- NCT number
- NCT07259980
- Sponsor
- Biogen
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-02
- Primary completion
- 2033-12-30
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.